IP Library › Granted Patent US 10,683,536
Granted Patent B2
US 10,683,536 · App. 14/829,269 · Granted Jun 16, 2020

Reusable initiators for synthesizing nucleic acids

Inventor: J. William Efcavitch (San Carlos, CA)
Assignee: Molecular Assemblies, Inc.
C12Q1/6844C07H21/02C07H21/04C12P19/34C12Q1/6806B01J2219/00596B01J2219/00722Y02P20/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,683,536
App. No.
14/829,269
Granted
Jun 16, 2020
Kind
B2
Abstract

The invention provides improved methods for synthesizing polynucleotides, such as DNA and RNA, using renewable initiators coupled to a solid support. Using the methods of the invention, specific sequences of polynucleotides can be synthesized de novo, base by base, in an aqueous environment, without the use of a nucleic acid template.

Claims (15)

1. A method for reversibly coupling a nucleotide analog to a solid support, the method comprising:

exposing a nucleic acid initiator attached to a solid support to nucleotide analogs in the presence of a polymerase, and in the absence of a template to create a first oligonucleotide;

contacting the nucleic acid initiator with a releasing agent to release the first oligonucleotide from the nucleic acid initiator, wherein the nucleic acid initiator remains a substrate for template-independent nucleic acid synthesis after release of the first oligonucleotide.

2. The method of claim 1 , wherein the polymerase is a nucleotidyl transferase or a modified nucleotidyl transferase.

3. The method of claim 1 , wherein the polymerase is terminal deoxynucleotidyl transferase (TdT) or a modified TdT.

4. The method of claim 1 , wherein the polymerase is poly-A polymerase or a modified poly-A polymerase.

5. The method of claim 1 , wherein the polymerase is poly-U polymerase or a modified poly-U polymerase.

6. The method of claim 1 , wherein the nucleotide analogs have an unmodified 3′-OH.

7. The method of claim 1 , wherein the nucleotide analogs have an unmodified 3′-OH and a cleavable terminating group, and wherein the cleavable terminating group blocks subsequent nucleotidyl transferase activity but results in a nucleotide substrate for nucleotidyl transferase upon cleavage of the terminating group.

8. The method of claim 1 , wherein the nucleotide analogs comprise a removable blocking moiety protecting the 3′ oxygen.

9. The method of claim 1 , wherein said nucleic acid initiator comprises a ribonucleotide.

10. The method of claim 1 , wherein said nucleic acid initiator comprises an abasic deoxyribose.

11. The method of claim 1 , wherein said nucleic acid initiator comprises an abasic ribose.

12. The method of claim 1 , wherein said nucleic acid initiator comprises a non-nucleoside 5′-monophosphate.

13. The method of claim 1 , wherein said releasing agent is a type II restriction nuclease.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: EFCAVITCH, J. WILLIAM
To: MOLECULAR ASSEMBLIES, INC.
Reel/Frame 043133/0300 →
Continuity (7)
Continuation In Part 14459014 · Aug 13, 2014
Continuation In Part 14056687 · Oct 17, 2013
Provisional Application 62069067 · Oct 27, 2014
Provisional Application 62038604 · Aug 18, 2014
Provisional Application 61891162 · Oct 15, 2013
Provisional Application 61807327 · Apr 2, 2013
Related Publication 20160046974A1 · Feb 18, 2016
Cited By (2)
US 12,344,876 US 12,421,628